Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Adenocarcinoma|Invasive Breast Carcinoma|Resectable Breast Carcinoma
Interventions: PROCEDURE: Biospecimen Collection|DRUG: Letrozole
Sponsor: Mayo Clinic